Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study

被引:57
作者
Fowler, Stephen J. [1 ,2 ,3 ]
Basanta-Sanchez, Maria [1 ,2 ]
Xu, Yun [4 ,5 ]
Goodacre, Royston [4 ,5 ]
Dark, Paul M. [1 ,2 ,6 ]
机构
[1] Univ Manchester, Univ S Manchester Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[2] Univ Manchester, Univ S Manchester Hosp, NIHR Resp & Allergy Clin Res Facil, Manchester, Lancs, England
[3] Lancashire Teaching Hosp NHS Fdn Trust, Preston, Lancs, England
[4] Univ Manchester, Sch Chem, Manchester, Lancs, England
[5] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England
[6] Salford Royal Hosp NHS Fdn Trust, Salford, Lancs, England
关键词
D O I
10.1136/thoraxjnl-2014-206273
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Healthcare associated infections, including ventilator associated pneumonia, are difficult to diagnose and treat, and are associated with significant morbidity, mortality and cost. We aimed to demonstrate proof of concept that breath volatile profiles were associated with the presence of clinically relevant pathogens in the lower respiratory tract. Methods Patients with sterile brain injury requiring intubation and ventilation on the intensive care unit were eligible for inclusion. Serial clinical and breath data were obtained three times a week, from admission up to a maximum of 10 days. Bronchial lavage for semiquantitative culture was collected immediately prior to breath sampling. Breath samples were collected in triplicate for off-line analysis by thermal-desorption/gas chromatography/time-of-flight mass spectrometry. Breath data were recorded as retention time/mass ion pairs, and analysed (pathogen present vs absent) by ANOVA-mean centre principal component analysis. Results Samples were collected from 46 patients (mean (SD) age 49 (19) years; 27 male). The dominant factors affecting breath sample analysis were the individual breath profile and duration of intubation. When these were taken into account, clear separation was seen between breath profiles at each time point by the presence/absence of pathogens. Loadings plots identified consistent metabolite peaks contributing to this separation at each time point. Conclusions Breath volatile analysis is able to classify breath profiles of patients with and without significant pathogen load in the lower respiratory tract. If validated in independent cohorts, these findings could lead to development of rapid non-invasive point-of-care surveillance systems and diagnostics for lower respiratory tract infection in the intensive care unit.
引用
收藏
页码:320 / 325
页数:6
相关论文
共 24 条
[2]  
[Anonymous], COMPTR AUD GEN RED H
[3]   Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers [J].
Basanta, Maria ;
Jarvis, Roger M. ;
Xu, Yun ;
Blackburn, Gavin ;
Tal-Singer, Ruth ;
Woodcock, Ashley ;
Singh, Dave ;
Goodacre, Royston ;
Thomas, C. L. Paul ;
Fowler, Stephen J. .
ANALYST, 2010, 135 (02) :315-320
[4]   Exhaled breath profiling for diagnosing acute respiratory distress syndrome [J].
Bos, Lieuwe D. J. ;
Schultz, Marcus J. ;
Sterk, Peter J. .
BMC PULMONARY MEDICINE, 2014, 14
[5]   Volatile Metabolites of Pathogens: A Systematic Review [J].
Bos, Lieuwe D. J. ;
Sterk, Peter J. ;
Schultz, Marcus J. .
PLOS PATHOGENS, 2013, 9 (05)
[6]   Statistical strategies for avoiding false discoveries in metabolomics and related experiments [J].
Broadhurst, David I. ;
Kell, Douglas B. .
METABOLOMICS, 2006, 2 (04) :171-196
[7]  
Davies S. C., 2013, ANN REPORT CHIEF MED, P259
[8]  
Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]
[9]   Surveillance non-directed bronchial lavage allows confident use of focused antibiotics in the management of ventilator-associated pneumonia [J].
Felton, Tim ;
Mount, Thomas ;
Chadwick, Paul ;
Ghrew, Murad ;
Dark, Paul .
JOURNAL OF INFECTION, 2010, 60 (05) :397-399
[10]  
GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819